| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
BMY sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 159.2K | $9.88M | - | |
| Dir | 34.1K | $1.83M | - | |
| VP | 25.9K | - | - | |
| VP | 21.4K | - | - | |
| VP | 19.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Elkins David V | EVP, Chief Financial Officer | Sell | 30,000 | $61.67 | $1,850,016.45 | -15.9% | -6.7% | - | |
| Sep 2, 2025 | Elkins David V | EVP, Chief Financial Officer | Sell | 56,000 | $47.33 | $2,650,480.00 | -25.1% | +3.7% | +42.7% | |
| Aug 2, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sale+OE | 378 | $44.23 | $16,718.94 | -6.9% | +4.2% | +48.0% | |
| May 9, 2025 | Hickey Benjamin | President, Rayzebio Org. | Sell | 97 | $38.01 | $3,701.83 | -100% | -2.3% | +20.9% | |
| Apr 25, 2025 | Hirawat Samit53 | EVP,Chief Med.offr.,Drug Dev. | Buy | 4,250 | $47.58 | $202,215.00 | +5.4% | +2.2% | +22.6% | |
| Feb 20, 2025 | Boerner Christopher S.60 | Chief Executive Officer | Buy | 2,000 | $55.05 | $110,096.00 | +1.9% | -15.8% | +8.7% | |
| Feb 14, 2025 | Hirawat Samit53 | EVP,Chief Med.offr.,Drug Dev. | Buy | 1,823 | $54.84 | $99,999.97 | +2.9% | -15.0% | +12.7% | |
| Nov 4, 2024 | Holzer Phil M | SVP and Controller | Sell | 700 | $55.62 | $38,930.50 | -5.6% | +8.1% | -17.8% | |
| Nov 1, 2024 | Hirawat Samit53 | EVP,Chief Med.offr.,Drug Dev. | Buy | 1,830 | $54.68 | $100,055.25 | +3.0% | +8.9% | -15.2% | |
| Dec 5, 2023 | Boerner Christopher S.60 | Chief Executive Officer | Buy | 2,000 | $49.78 | $99,560.00 | +2.5% | +1.4% | +16.2% |